Mechanistic Insights and Therapeutic Potential of MCC950 as a NLRP3 Inflammasome Inhibitor in Multiple Sclerosis: A Narrative Review.

Rabiei F, Askari H, Vala A, Mardazad M, Ghasemi-Kasman M

Curr Rev Clin Exp Pharmacol. 2026 May 11. PMID: 42152629. Abstract